News

Cardiosonic Inc CE mark TIVUS ablative catheter renal denervation hypertension

Cardiosonic Ltd. announced CE marking of its TIVUS (therapeutic intravascular ultrasound) ablative catheter device.

Advanced Visualization Artificial Hear Heart Repair Arizona State University

An Arizona State University research group and medical professionals at Phoenix Children’s Hospital are achieving some firsts in the history of artificial heart implantation.

heartware lvads vanderbilt heart heartmate

April 25, 2014 — Vanderbilt Heart and Vascular Institute (VHVI) was the first facility in Tennessee to implant the miniaturized HeartWare HVAD pump through a minimally invasive approach known as a...

Virtual Surgical Planning 3-D Planning Systems Advanced Visualization

3D Systems announced that its Medical Modeling Virtual Surgical Planning (VSP) technology — the combination of its production grade 3-D printing and personalized surgery tools — has enabled...

ACC.14 Astronauts Clinical Trial Cardiovascular Ultrasound

New findings from a study of 12 astronauts show the heart becomes more spherical when exposed to long periods of microgravity in space, a change that could lead to cardiac problems, according to...

Manny Villafana, chairman and CEO of Kips Bay Medical Inc., announced that on Jan. 14, 2014, the first commercial implant of the company's eSVS Mesh in Austria was performed at the Medical...

April 24, 2014 — SCL Health System, a faith-based, nonprofit healthcare organization, announced an agreement to implement Stanson Health's next-generation clinical decision support (CDS) system....

April 24, 2014 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for its latest generation of defibrillators and heart failure devices. The newly approved...

Singulex Blood Test Clinical Study American Heart Association

Singulex Inc. presented new data at the American Heart Association Epidemiology and Prevention Council Conference highlighting research results using the company’s proprietary ultrasensitive...

Allison Morgan was in pretty bad shape when the medical helicopter touched down on the rooftop helipad of the University of Alabama at Birmingham Hospital (UAB).

ICD Heart Failure Treatments VAD California Boston Scientific

Three weeks after delivering her first child, Amanda began to suffer from extreme fatigue, headaches, a tight chest and stomach pain. An initial diagnosis of pneumonia changed for the worse:...

Interim results from The Chocolate Bar Registry conducted in the United States demonstrate that use of the Chocolate PTA balloon achieved high rates of treatment success and limb preservation in...

April 23, 2014 — Vital Images, a Toshiba Medical Systems Group company, is experiencing a significant increased demand for its VitreaView universal viewer as healthcare leaders seek opportunities...

April 23, 2014 — The PROCEED II heart transplant U.S. Food and Drug Administration (FDA) pivotal trial results using the Organ Care System (OCS) Heart platform were announced at the International...

April 23, 2014 — Xeltis announced it finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural,...

April 23, 2014 — Philips Healthcare has completed its first field study for its Minicare handheld cardiac Troponin-I (cTn-I) blood test, demonstrating the platform’s potential to produce...

Corevalve, FDA, Edwards, TAVR, TAVI, lawsuit, injunction

The Federal Circuit Court of Appeals granted a request from Medtronic Inc. to postpone the implementation of an injunction that would have prevented the company from selling its CoreValve System...

 Loyola University Medical Center is now offering patients the most advanced positron emission tomography/computed tomography (PET/CT) scanner on the market.

FDA Clearnace Volcano Corp. iFR Modality FFR Catheter Cath Lab

Volcano Corp. announced U.S. Food and Drug Administration (FDA) clearance of its proprietary Instant Wave-Free Ratio (iFR) modality.

April 21, 2014 — Decision Resources Group announced in a report that Servier's ivabradine (procoralan) is set to become the clinical gold standard in the treatment of chronic heart failure (...